113 related articles for article (PubMed ID: 6214207)
1. Prostaglandins and the immune response to cancer (review).
Ceuppens J; Goodwin J
Anticancer Res; 1981; 1(2):71-8. PubMed ID: 6214207
[No Abstract] [Full Text] [Related]
2. Prostaglandins, immunity and their effect on tumour growth.
Ablin RJ
Allergol Immunopathol (Madr); 1985; 13(2):157-60. PubMed ID: 3890502
[TBL] [Abstract][Full Text] [Related]
3. COX-2 inhibitors as radiosensitizing agents for cancer therapy.
Davis TW; Hunter N; Trifan OC; Milas L; Masferrer JL
Am J Clin Oncol; 2003 Aug; 26(4):S58-61. PubMed ID: 12902857
[TBL] [Abstract][Full Text] [Related]
4. Third annual Sapporo Cancer Seminar. Biological responses in cancer chemotherapy.
Cancer Res; 1983 Dec; 43(12 Pt 1):6109-12. PubMed ID: 6227384
[No Abstract] [Full Text] [Related]
5. Mechanism of action of nonsteroidal anti-inflammatory agents.
Goodwin JS
Postgrad Med; 1983 May; Spec No():23-31. PubMed ID: 6224141
[No Abstract] [Full Text] [Related]
6. Exploiting cancer cell cycling for selective protection of normal cells.
Blagosklonny MV; Pardee AB
Cancer Res; 2001 Jun; 61(11):4301-5. PubMed ID: 11389048
[TBL] [Abstract][Full Text] [Related]
7. [Mucin-mediated tumor progression].
Hiroshi N
Tanpakushitsu Kakusan Koso; 2008 Sep; 53(12 Suppl):1604-10. PubMed ID: 21089374
[No Abstract] [Full Text] [Related]
8. Prostaglandin E2 production by human tumors. Defense mechanism against the host? A preliminary report.
Attallah A; Lee JB; Ambrus JL; Ambrus CM; Karakousis C; Takita H
Res Commun Chem Pathol Pharmacol; 1984 Feb; 43(2):195-201. PubMed ID: 6584944
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandins and cancer: a review of tumor initiation through tumor metastasis.
Honn KV; Bockman RS; Marnett LJ
Prostaglandins; 1981 May; 21(5):833-64. PubMed ID: 6280245
[No Abstract] [Full Text] [Related]
10. Immunomodulation by cancer chemotherapeutic agents and antineoplastic activity.
Spreafico F; Mantovani A
Pathobiol Annu; 1981; 11():177-95. PubMed ID: 6460217
[No Abstract] [Full Text] [Related]
11. [Subpopulations of human T-lymphocytes and their suppressor functions].
Brondz BD
Ter Arkh; 1980; 52(9):120-32. PubMed ID: 6449090
[No Abstract] [Full Text] [Related]
12. Antitumor agents and the molecular basis of cancer.
Bloch AW
Prog Clin Biol Res; 1985; 172B():207-13. PubMed ID: 3991709
[No Abstract] [Full Text] [Related]
13. Cellular mechanisms of specific immunostimulation.
Bomford R
Int J Tissue React; 1982; 4(3):201-5. PubMed ID: 6216205
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T cells and Toll-like receptors in tumor immunity.
Wang RF; Peng G; Wang HY
Semin Immunol; 2006 Apr; 18(2):136-42. PubMed ID: 16469504
[TBL] [Abstract][Full Text] [Related]
15. [Effect of chemotherapy on anticancer immune effector cells].
Saijo N
Gan To Kagaku Ryoho; 1983 Mar; 10(3):699-707. PubMed ID: 6410999
[TBL] [Abstract][Full Text] [Related]
16. The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression.
Ghiringhelli F; Ménard C; Martin F; Zitvogel L
Immunol Rev; 2006 Dec; 214():229-38. PubMed ID: 17100888
[TBL] [Abstract][Full Text] [Related]
17. The in vivo regulation of splenic T cell population by the prostaglandin-mediated system.
Taniguchi K; Koga Y; Kato M; Nomoto K
J Clin Lab Immunol; 1984 Aug; 14(4):195-203. PubMed ID: 6238169
[TBL] [Abstract][Full Text] [Related]
18. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
Ding XZ; Tong WG; Adrian TE
Anticancer Res; 2000; 20(4):2625-31. PubMed ID: 10953335
[TBL] [Abstract][Full Text] [Related]
19. [Cytochrome P450s and cancer].
Lu H; Li Y
Sheng Li Ke Xue Jin Zhan; 1997 Apr; 28(2):178-80. PubMed ID: 11038721
[No Abstract] [Full Text] [Related]
20. Sensitivity of preincubated lymphocytes to suppressor regulation.
Kalmár L; Gergely P; Nékám K; Gonzalez R
Acta Med Hung; 1983; 40(4):195-202. PubMed ID: 6232498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
